Potential phytomedicines against COVID-19: A review

COVID-19 is a pandemic disease and has affected more than 5.8 million people across the world. Given the alarming desolation and transience of COVID-19, it is understandable to identify phytomedicine's contingency use to lead to a new indication of anti-COVID-19 drug build on evidence. To summarize the potential phyto-drugs formulae provided to treat COVID-19 patients, we designed a non-systematic review of the recent literature. Five data sources (PubMed, Embase, Web of Sciences, Google Scholar and Chinese guidelines on novel coronavirus) were preferred to identify presented potential phytomedicines for COVID-19 treatment. This literature study showed the anti-COVID-19 potential of wielded phytochemicals. The study regards plant-derived composites such as chloroquine phosphate, diammonium glycyrrhizinate, artemisinin, luteolin-7-glucoside and kaempferol as suitable agents for the COVID-19 antiviral therapy. Moreover, the use of curcumin and recommended TCMs for the expression of the nCOV-19 antigens can be a target for the future antiviral drug of the COVID-19 due to the intrinsic antiviral properties. We hope that present review will serve as a reference and guidance for the identification of potential antiviral compounds and/or drugs for COVID-19 treatment.